2021 NICE指南:新生儿感染的抗生素预防和治疗(NG.195)

2021-04-20 英国国家卫生与临床优化研究所 NICE官网

2021年4月,英国国家卫生与临床优化研究所 (NICE)发布了新生儿感染的抗生素预防和治疗指南。主要内容涵盖了校正胎龄28日以下的健康婴儿,具有感染风险的未出生婴儿以及28日校正胎龄的疑似或确诊细菌

中文标题:

2021 NICE指南:新生儿感染的抗生素预防和治疗(NG.195)

英文标题:

NICE guideline [NG195]:Neonatal infection: antibiotics for prevention and treatment

发布日期:

2021-04-20

简要介绍:

2021年4月,英国国家卫生与临床优化研究所 (NICE)发布了新生儿感染的抗生素预防和治疗指南。主要内容涵盖了校正胎龄28日以下的健康婴儿,具有感染风险的未出生婴儿以及28日校正胎龄的疑似或确诊细菌感染的婴儿的细菌感染的预防和治疗。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 NICE指南:新生儿感染的抗生素预防和治疗(NG.195).pdf)] GetToolGuiderByIdResponse(projectId=1, id=88a631c002098a8f, title=2021 NICE指南:新生儿感染的抗生素预防和治疗(NG.195), enTitle=NICE guideline [NG195]:Neonatal infection: antibiotics for prevention and treatment, guiderFrom=NICE官网, authorId=0, author=, summary=2021年4月,英国国家卫生与临床优化研究所 (NICE)发布了新生儿感染的抗生素预防和治疗指南。主要内容涵盖了校正胎龄28日以下的健康婴儿,具有感染风险的未出生婴儿以及28日校正胎龄的疑似或确诊细菌, cover=https://img.medsci.cn/2021516/1621128767842_2020535.jpg, journalId=0, articlesId=null, associationId=85, associationName=英国国家卫生与临床优化研究所, associationIntro=英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence)是NHS的组织,设在伦敦和曼彻斯特。NICE成立于1999年4月1日,目标是确保每个英格兰和威尔士人平等享有NHS医疗的机会。NICE制定指南,设定质量标准,管理国家数据库,为NHS、当地权威部门和其他组织提供指南。, copyright=0, guiderPublishedTime=Tue Apr 20 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年4月,英国国家卫生与临床优化研究所 (NICE)发布了新生儿感染的抗生素预防和治疗指南。主要内容涵盖了校正胎龄28日以下的健康婴儿,具有感染风险的未出生婴儿以及28日校正胎龄的疑似或确诊细菌感染的婴儿的细菌感染的预防和治疗。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=77157, tagName=新生儿感染)], categoryList=[CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=77157, guiderKeyword=新生儿感染, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8645, appHits=387, showAppHits=0, pcHits=1432, showPcHits=8256, likes=3, shares=87, comments=29, approvalStatus=1, publishedTime=Sun May 16 09:44:14 CST 2021, publishedTimeString=2021-04-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun May 16 09:32:54 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 21:30:10 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 NICE指南:新生儿感染的抗生素预防和治疗(NG.195).pdf)])
2021 NICE指南:新生儿感染的抗生素预防和治疗(NG.195).pdf
下载请点击:
评论区 (25)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2126968, encodeId=a48d212696851, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/A3uP9GeM85N0l7yXk4kZtg8JN4OgswDl4o4myibZhEc6ejwMSqY0YSBXhw5MaKb67CIlvHYZTwwD22Yia1uKulrw/132, createdBy=7cf92207353, createdName=120c9f85m92(暂无昵称), createdTime=Wed Apr 19 09:37:51 CST 2023, time=2023-04-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1185003, encodeId=90c311850036d, content=不错,学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sun Jan 16 23:31:42 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182149, encodeId=bd391182149b3, content=不错,学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sat Jan 08 10:36:56 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179295, encodeId=5b3511e9295cc, content=不错学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Fri Dec 31 14:44:52 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084666, encodeId=bc821084666c7, content=不错学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Mon Dec 27 13:56:42 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2023-04-19 120c9f85m92(暂无昵称) 来自上海

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2126968, encodeId=a48d212696851, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/A3uP9GeM85N0l7yXk4kZtg8JN4OgswDl4o4myibZhEc6ejwMSqY0YSBXhw5MaKb67CIlvHYZTwwD22Yia1uKulrw/132, createdBy=7cf92207353, createdName=120c9f85m92(暂无昵称), createdTime=Wed Apr 19 09:37:51 CST 2023, time=2023-04-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1185003, encodeId=90c311850036d, content=不错,学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sun Jan 16 23:31:42 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182149, encodeId=bd391182149b3, content=不错,学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sat Jan 08 10:36:56 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179295, encodeId=5b3511e9295cc, content=不错学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Fri Dec 31 14:44:52 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084666, encodeId=bc821084666c7, content=不错学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Mon Dec 27 13:56:42 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2022-01-16 仁术2021

    不错,学习了。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2126968, encodeId=a48d212696851, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/A3uP9GeM85N0l7yXk4kZtg8JN4OgswDl4o4myibZhEc6ejwMSqY0YSBXhw5MaKb67CIlvHYZTwwD22Yia1uKulrw/132, createdBy=7cf92207353, createdName=120c9f85m92(暂无昵称), createdTime=Wed Apr 19 09:37:51 CST 2023, time=2023-04-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1185003, encodeId=90c311850036d, content=不错,学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sun Jan 16 23:31:42 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182149, encodeId=bd391182149b3, content=不错,学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sat Jan 08 10:36:56 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179295, encodeId=5b3511e9295cc, content=不错学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Fri Dec 31 14:44:52 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084666, encodeId=bc821084666c7, content=不错学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Mon Dec 27 13:56:42 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2022-01-08 仁术2021

    不错,学习了。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2126968, encodeId=a48d212696851, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/A3uP9GeM85N0l7yXk4kZtg8JN4OgswDl4o4myibZhEc6ejwMSqY0YSBXhw5MaKb67CIlvHYZTwwD22Yia1uKulrw/132, createdBy=7cf92207353, createdName=120c9f85m92(暂无昵称), createdTime=Wed Apr 19 09:37:51 CST 2023, time=2023-04-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1185003, encodeId=90c311850036d, content=不错,学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sun Jan 16 23:31:42 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182149, encodeId=bd391182149b3, content=不错,学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sat Jan 08 10:36:56 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179295, encodeId=5b3511e9295cc, content=不错学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Fri Dec 31 14:44:52 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084666, encodeId=bc821084666c7, content=不错学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Mon Dec 27 13:56:42 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2021-12-31 仁术2021

    不错学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2126968, encodeId=a48d212696851, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/A3uP9GeM85N0l7yXk4kZtg8JN4OgswDl4o4myibZhEc6ejwMSqY0YSBXhw5MaKb67CIlvHYZTwwD22Yia1uKulrw/132, createdBy=7cf92207353, createdName=120c9f85m92(暂无昵称), createdTime=Wed Apr 19 09:37:51 CST 2023, time=2023-04-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1185003, encodeId=90c311850036d, content=不错,学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sun Jan 16 23:31:42 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182149, encodeId=bd391182149b3, content=不错,学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sat Jan 08 10:36:56 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179295, encodeId=5b3511e9295cc, content=不错学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Fri Dec 31 14:44:52 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084666, encodeId=bc821084666c7, content=不错学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Mon Dec 27 13:56:42 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2021-12-27 仁术2021

    不错学习了。

    0

拓展阅读

2024 NICE 质量标准:新生儿感染【QS75】

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2024-01-23

2024 NICE 指南:新生儿感染的抗生素预防和治疗 [NG195]

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2024-03-19